JW Therapeutics

JW Therapeutics

JW Therapeutics

JW Therapeutics is an independent Chinese immunocell therapy company focus on the Great China cancer market.
Founded
2016
Raised
$280M
Follow us
Alexa global traffic share
10 Jun 2020
$100,000,000
Venture capital (Series B)

Chinese Biotech Firm JW Therapeutics Closes $100M Series B Round

ChinaMoneyNetwork
+2
08 Mar 2018
$90,000,000
Venture capital (Series A)

JW Therapeutics Raises $90M in Series A Financing

FinSMEs
+1
07 Mar 2018
$90,000,000
Venture capital (Series A)